- Advertisement -
(Bloomberg) — Molecular testing firm Qiagen NV and French rival BioMerieux are exploring a potential combination that would unite two of Europe’s biggest medical diagnostics providers, people with knowledge of the matter said.
Most Read from Bloomberg
- …

